Journal article
Biocompatible ligand balancing in transition metal coordination enables benign in-cell protein arylation
- Abstract:
- Metal-mediated chemistries now find increasing application in in vitro biomolecule modification. However, the perceived and potential toxicity of some metals has limited the application of organometallic reagents in more complex biological settings such as inside living cells. Ligands play a crucial role in modulating both the reactivity and availability of transition metals. Here we reveal that organonickel-mediated S-arylation tolerates flexible chelation with biocompatible ligands without destroying the chemical reactivity of corresponding aryl-nickel reagents, enabling the creation of safe, site-selective C–S-bond-forming arylation manifolds. These balanced systems prove sufficiently benign for use on diverse protein substrates in vitro and in living prokaryotic and eukaryotic cells. This, in turn, enables deep chemical surveys of reactive cysteines in human cells with sensitivity sufficient to detect covalently targetable proteins from emerging intracellular viral and bacterial pathogens. Biocompatible ligand balancing thus offers a path to the broader use of transition metals in living systems.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 15.0MB, Terms of use)
-
(Supplementary materials, zip, 7.1MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41557-025-02017-1
Authors
- Publisher:
- Nature Research
- Journal:
- Nature Chemistry More from this journal
- Volume:
- 18
- Issue:
- 3
- Pages:
- 457-472
- Publication date:
- 2026-01-07
- Acceptance date:
- 2025-10-28
- DOI:
- EISSN:
-
1755-4349
- ISSN:
-
1755-4330
- Language:
-
English
- Keywords:
- Pubs id:
-
2357691
- Local pid:
-
pubs:2357691
- Source identifiers:
-
3828878
- Deposit date:
-
2026-03-06
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record